ArticleJournal, genetic engineering & biotechnology2025
Efficient and cost-effective shoot regeneration in Aguaymanto (Physalis peruviana L.) using meta-Topolin and 6-benzylaminopurine combinations.
Article in Journal, genetic engineering & biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Physalis peruviana L. (known as aguaymanto or goldenberry) is a high-value Andean fruit crop with growing international demand due to its nutritional and nutraceutical properties. However, the development of advanced biotechnological tools for this species has been limited by the lack of efficient and reproducible in vitro regeneration protocols. Existing systems rely primarily on the use of zeatin, a highly effective but expensive cytokinin, which restricts their applicability in resource-limited laboratories. In this study, the synergistic effect of 6-benzylaminopurine (BAP) and meta-topolin (mT) on adventitious shoot regeneration from cotyledonary explants of P. peruviana was evaluated. An initial cytokinin screening identified BAP + mT as the most promising combination, and subsequent optimization revealed that the combination of 9.12 µM BAP with 2.28 µM mT promoted the highest shoot regeneration rate (62.96 %), outperforming previously reported zeatin-based protocols. This treatment also significantly enhanced shoot elongation and rhizogenesis without inducing morphological abnormalities. These results position the BAP + mT combination as an economically viable alternative to replace the use of zeatin in regeneration protocols, with potential applications in genetic transformation programs, in vitro propagation, and the improvement of species in the genus Physalis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.